期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 759, 期 -, 页码 182-191出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2015.03.042
关键词
Multiple Sclerosis; EAE; Immune system
资金
- European Union IDEAS Programme European Research Council Starting Grant menTORingTregs [310496]
- Fondazione Italiana Sclerosi Multipla (FISM) [2012/R/11]
- CNR-Medicina Personalizzata
- Ministero della Salute [GR-2010-2315414]
- Fondo per gli Investimenti della Ricerca di Base (FIRB) [RBFR12I3UB_004]
Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) which involves a complex interaction between immune system and neural cells. Animal modeling has been critical for addressing MS pathogenesis. The three most characterized animal models of MS are (1) the experimental autoimmune/allergic encephalomyelitis (EAE); (2) the virally-induced chronic demyelinating disease, known as Theiler's murine encephalomyelitis virus (TMEV) infection and (3) the toxin-induced demyelination. All these models, in a complementary way, have allowed to reach a good knowledge of the pathogenesis of MS. Specifically, EAE is the model which better reflects the autoimmune pathogenesis of MS and is extremely useful to study potential experimental treatments. Furthermore, both TMEV and toxin-induced demyelination models are suitable for characterizing the role of the axonal injury/repair and the remyelination process in MS. In conclusion, animal models, despite their limitations, remain the most useful instrument for implementing the study of MS. (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据